Post by icemandios on Oct 1, 2020 13:00:27 GMT
ViewRay to Host Physician-led Webinar for Investors and Analysts at the 2020 American Society of Radiation Oncology (ASTRO) Annual Meeting
CLEVELAND , Oct. 1, 2020 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) today announced that the Company will host a virtual physician-led informational discussion for investors and analysts during the 2020 American Society of Radiation Oncology (ASTRO) Annual Meeting.
Event: Physician-led Webinar for Investors and Analysts at 2020 ASTRO Annual Meeting
Date: Tuesday, October 27, 2020
Time: 9:00 a.m. – 10:00 a.m. MTN
Details:
Registration is required to attend and will close an hour prior to the start.
Please register at www.bigmarker.com/viewray/Physician-led-Webinar-for-Investors-and-Analysts-at-2020-ASTRO-Annual-Meeting?utm_bmcr_source=Press .
An archived replay of the meeting will be available within 24 hours on ViewRay's investor relations website at investors.viewray.com/events-and-presentations/upcoming-events.
Guest Speakers :
Dr. John Bayouth is a tenured professor and the Bhudatt Paliwal endowed chair of the Radiation Oncology Physics Division in the Department of Human Oncology at the University of Wisconsin in Madison, one of the nation's premier radiation oncology physics programs. He is also the director of the UW–Madison Medical Physics Residency Program in Radiation Therapy. Dr. Bayouth has served in the presidential chair of both the American Association of Physics in Medicine (AAPM) and the Society of Directors of Academic Medical Physics Programs (SDAMPP) and within various committees of the American Society of Radiation Oncology (ASTRO), the Radiological Society of North America (RSNA), and the American Board of Radiology (ABR).
Daphne Haas-Kogan, MD, is Chair of the Department of Radiation Oncology at Dana-Farber/Brigham and Women's Cancer Center (DFBWCC) and Boston Children's Hospital. She is also the Willem and Corrie Hees Family Professor of Radiation Oncology at Harvard Medical School. As Department Chair, her vision includes supporting each member of the Radiation Oncology Department in fostering close collaborative ties with diagnostic radiologists, medical and pediatric oncologists, surgeons, pathologists, and basic science investigators to spearhead cutting edge science, translational investigations and clinical studies, all based on the depth and breadth of success that already permeates DFBWCC. Dr. Haas-Kogan is a member of the National Academy of Medicine.
A question and answer session will be held at the end of the presentation.
ViewRay, Inc. (Nasdaq: VRAY), designs, manufactures and markets the MRIdian ® radiation therapy system. MRIdian is built upon a proprietary high-definition MR imaging system designed from the ground up to address the unique challenges and clinical workflow for advanced radiation oncology. Unlike MR systems used in diagnostic radiology, MRIdian's high-definition MR was purpose built to address specific challenges, including beam distortion, skin toxicity, and other concerns that potentially may arise when high magnetic fields interact with radiation beams. ViewRay and MRIdian are registered trademarks of ViewRay, Inc.